Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,076 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Update results of FEC followed by docetaxel neoadjuvant trials for primary breast cancer.
Ohnoa S, Toi M, Kuroi K, Nakamura S, Iwata H, Kusama M, Masuda N, Yamazaki K, Hisamatsu K, Sato Y, Takatsuka Y, Shin E, Kaise H, Kurozumi M, Tsuda H, Akiyama F. Ohnoa S, et al. Among authors: nakamura s. Biomed Pharmacother. 2005 Oct;59 Suppl 2:S323-4. doi: 10.1016/s0753-3322(05)80063-0. Biomed Pharmacother. 2005. PMID: 16507401
Correlation between docetaxel-induced skin toxicity and the use of steroids and H₂ blockers: a multi-institution survey.
Kawaguchi K, Ishiguro H, Morita S, Nakamura S, Ohno S, Masuda N, Iwata H, Aogi K, Kuroi K, Toi M; Japan Breast Cancer Research Group (JBCRG). Kawaguchi K, et al. Among authors: nakamura s. Breast Cancer Res Treat. 2011 Nov;130(2):627-34. doi: 10.1007/s10549-011-1641-9. Epub 2011 Jun 23. Breast Cancer Res Treat. 2011. PMID: 21698408 Free article.
Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil– epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy.
Ohno S, Chow LW, Sato N, Masuda N, Sasano H, Takahashi F, Bando H, Iwata H, Morimoto T, Kamigaki S, Nakayama T, Nakamura S, Kuroi K, Aogi K, Kashiwaba M, Yamashita H, Hisamatsu K, Ito Y, Yamamoto Y, Ueno T, Fakhrejahani E, Yoshida N, Toi M. Ohno S, et al. Among authors: nakamura s. Breast Cancer Res Treat. 2013 Nov;142(1):69-80. doi: 10.1007/s10549-013-2691-y. Breast Cancer Res Treat. 2013. PMID: 24122389 Free PMC article. Clinical Trial.
Molecular detection of lymph node metastasis in breast cancer patients treated with preoperative systemic chemotherapy: a prospective multicentre trial using the one-step nucleic acid amplification assay.
Osako T, Tsuda H, Horii R, Iwase T, Yamauchi H, Yagata H, Tsugawa K, Suzuki K, Kinoshita T, Akiyama F, Nakamura S. Osako T, et al. Among authors: nakamura s. Br J Cancer. 2013 Sep 17;109(6):1693-8. doi: 10.1038/bjc.2013.503. Epub 2013 Sep 3. Br J Cancer. 2013. PMID: 24002597 Free PMC article.
Outcomes of fulvestrant therapy among japanese women with advanced breast cancer: a retrospective multicenter cohort study (JBCRG-C06; Safari).
Kawaguchi H, Masuda N, Nakayama T, Aogi K, Anan K, Ito Y, Ohtani S, Sato N, Saji S, Tokunaga E, Nakamura S, Hasegawa Y, Hattori M, Fujisawa T, Morita S, Yamaguchi M, Yamashita T, Yamamoto Y, Ohno S, Toi M. Kawaguchi H, et al. Among authors: nakamura s. Breast Cancer Res Treat. 2017 Jun;163(3):545-554. doi: 10.1007/s10549-017-4212-x. Epub 2017 Mar 23. Breast Cancer Res Treat. 2017. PMID: 28337663
Three dose regimens of fulvestrant in postmenopausal Japanese women with advanced breast cancer: results from a double-blind, phase II comparative study (FINDER1).
Ohno S, Rai Y, Iwata H, Yamamoto N, Yoshida M, Iwase H, Masuda N, Nakamura S, Taniguchi H, Kamigaki S, Noguchi S. Ohno S, et al. Among authors: nakamura s. Ann Oncol. 2010 Dec;21(12):2342-2347. doi: 10.1093/annonc/mdq249. Epub 2010 May 21. Ann Oncol. 2010. PMID: 20494961 Free article. Clinical Trial.
Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies.
Toi M, Iwata H, Fujiwara Y, Ito Y, Nakamura S, Tokuda Y, Taguchi T, Rai Y, Aogi K, Arai T, Watanabe J, Wakamatsu T, Katsura K, Ellis CE, Gagnon RC, Allen KE, Sasaki Y, Takashima S. Toi M, et al. Among authors: nakamura s. Br J Cancer. 2009 Nov 17;101(10):1676-82. doi: 10.1038/sj.bjc.6605343. Epub 2009 Oct 20. Br J Cancer. 2009. PMID: 19844234 Free PMC article. Clinical Trial.
11,076 results
You have reached the last available page of results. Please see the User Guide for more information.